Onconetix (ONCO) Common Equity (2023 - 2025)
Historic Common Equity for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $3.4 million.
- Onconetix's Common Equity fell 9177.5% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 9177.5%. This contributed to the annual value of $8.5 million for FY2024, which is 50824.3% up from last year.
- As of Q3 2025, Onconetix's Common Equity stood at $3.4 million, which was down 9177.5% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Onconetix's Common Equity ranged from a high of $41.0 million in Q3 2024 and a low of -$28.7 million during Q2 2024
- Over the past 3 years, Onconetix's median Common Equity value was $5.9 million (recorded in 2025), while the average stood at $5.8 million.
- The largest annual percentage gain for Onconetix's Common Equity in the last 5 years was 50824.3% (2024), contrasted with its biggest fall of 31970.63% (2024).
- Quarter analysis of 3 years shows Onconetix's Common Equity stood at $1.4 million in 2023, then skyrocketed by 508.24% to $8.5 million in 2024, then crashed by 60.5% to $3.4 million in 2025.
- Its Common Equity was $3.4 million in Q3 2025, compared to $5.9 million in Q2 2025 and $4.0 million in Q1 2025.